You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. DetectID: Improving the Detection of Impaired Driving Through Virtual Reality Training

    SBC: Innovation Research And Training, Inc.            Topic: 23NH2

    Impaired driving due to alcohol and drugs is a significant public health and safety problem in the U.S. The detection and enforcement of impaired driving laws are key to reducing this problem. Virtual reality training has the potential to support law enforcement officers in obtaining the necessary knowledge and skills to effectively detect impaired drivers. DetectID will be an immersive, accessibl ...

    SBIR Phase I 2023 Department of Transportation
  2. Digital Human Model for Use in Simulation Environments for Tactile Human/Robot Interactions

    SBC: CORVID TECHNOLOGIES, LLC            Topic: DHA213008

    Corvid Technologies, LLC and Stevens Institute of Technology (Stevens) propose to utilize the results and lessons learned from the Phase I effort to develop and demonstrate a digital human body model capable of quantifying internal stresses and strains in the anatomy and joint loads due to externally applied forces from robotic manipulation. Similar to the approach in Phase I, the proposed approac ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  3. Combat Oxygenation Device to Remedy ARDS

    SBC: BOUNDLESS SCIENCE, LLC            Topic: DHA231004

    The COMBAT OXYGENATION DEVICE (COD) is a small, portable device that provides instant oxygenation and CO2 removal for warfighters with battle-compromised lungs on the battlefield, specifically from blast, chemical, and biological attacks, targeting the subsequent Acute Respiratory Distress Syndrome (ARDS) which results. This device gently rejuvenates damaged lungs by spraying an oxygenated li ...

    SBIR Phase I 2023 Department of DefenseDefense Health Agency
  4. Radio Location Tracker Mobile Mesh System

    SBC: WISER Systems, Inc.            Topic: USDA813

    WISER Systems, Inc. is a small, woman-owned, disadvantaged business providing best-in-class real-time location systems (RTLS) for nearly any environment. WISER’s RTLS powers applications in aerospace, manufacturing, warehousing, yard management, and many other industries. Unlike GPS-based solutions, WISER’s Redundant Radio Localization and Tracking (RRLT) technology enables autonomous position ...

    SBIR Phase II 2023 Department of DefenseSpecial Operations Command
  5. Novel Aerosol Therapy for Immediate and Sustained ARDS Management

    SBC: ZYMERON CORPORATION            Topic: DHA231004

    The acute respiratory distress syndrome (ARDS) is a common cause of respiratory failure in critically ill patients and is characterized by failure of oxygen (O2) and carbon dioxide (CO2) movement (gas exchange) across the alveolar-capillary membrane. Despite its high mortality rate of 30-50%, there are currently no definitive pharmacologic therapies for ARDS. Thus, there is a pressing requirement ...

    SBIR Phase I 2023 Department of DefenseDefense Health Agency
  6. Development for ShockDefender against Hemorrhagic Shock

    SBC: ZYMERON CORPORATION            Topic: DHA234D001

    Hemorrhagic shock is responsible for over 35% of prehospital traumatic deaths and over 40% of all deaths within the first 24 hours following injury. Multiple intervention strategies are necessary for prolonged prehospital management and improved casualty survivability including improved blood products, hemostatics, damage control resuscitation, as well as therapeutic interventions targeting coagul ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  7. nXcomms: Intelligent Patient Simulation

    SBC: BIOMOJO LLC            Topic: DHA191002

    The purpose of this SBIR topics is to define, demonstrate, develop, and test an Intelligent Patient Simulation software architecture to be used for building intelligent patient simulators that provide realistic medical training experiences, by leveraging natural language processing and advanced Artificial Intelligence (AI) technologies.

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
  8. Digital Human Model for Use in Simulation Environments for Tactile Human/Robot Interaction

    SBC: CORVID TECHNOLOGIES, LLC            Topic: DHA213008

    There is growing interest in the use of robotics and autonomous systems (RAS) in search-andrescue missions. The need for smart human-robot-interaction (HRI) systems in these application areas becomes critical as deployed robots have to collaborate and cooperate with human rescue teams in fast changing and dynamic environments. In addition to environmental variability, the HRI systems need to ensur ...

    SBIR Phase I 2022 Department of DefenseDefense Health Agency
  9. Military Working Dog Hearing Protection/Active Communication System

    SBC: VADUM INC            Topic: A17132

    Vadum and K9 Helm propose to combine Vadum canine Hearing Protection (HP) technologies (including both passive and active protection modes) with K9 Helm Military Working Dog (MWD) helmet technologies. The K9 Helm products provide several additional functions (beyond HP) including eye protection, muzzle functionality, and mounting points for other sensors. The combined functionality supports freque ...

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
  10. Novel Antibiotics Targeting Multidrug-Resistant Pseudomonas Aeruginosa Infections

    SBC: ZYMERON CORPORATION            Topic: DHA211008

    The management of infection caused by multidrug-resistant (MDR) Pseudomonas aeruginosa is becoming a major clinical challenge due to the rapid evolution of antibiotic resistant bacteria. P. aeruginosa is one of the most common gram-negative bacteria implicated in nosocomial infection and the second most common pathogen implicated in ventilator-associated pneumonia (VAP). The excessive use of antib ...

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government